Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

CStone Pharmaceuticals

2616.HK ✓ COMPLIANT ☆ Track — members

HKEX · Healthcare · Pharmaceuticals ·

Hong Kong Small Cap Analyst: BUY

Last Close

$0.71

▲ +3.06%

Market Cap $1.13B · Vol 6.80M

Key Metrics

P/E Ratio

N/A

FWD: 11.53

Market Cap

$1.13B

Small Cap

Div Yield

N/A

EPS Growth

+109.71%

YoY

RSI (14)

67.58

Momentum

Beta

1.05

vs Market

52W High

$1.68

58.03% below

52W Low

$0.51

38.41% above

Volume

6.80M

Avg 6.36M

P/B

11.33

Price-to-book

ROE

-89.13%

Return on equity

Free Float

80.15%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, CStone Pharmaceuticals (2616.HK) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does 2616.HK pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-1.25%

+20.13%

-30.80%

-12.74%

YTD

+5.31%

-42.43%

+141.54%

-57.11%

Financials & Valuation

TTM · Annual

Total Revenue	$38.55M
Net Income	$-62,490,598.00
Revenue Growth (YoY)	+43.84%
Gross Margin	19.01%
Operating Margin	-148.62%
Net Profit Margin	-162.10%
ROE	-89.13%
ROA · ROIC	-30.81% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	11.53
PEG Ratio	N/A
P/S	24.39
P/B	11.33
P/FCF	N/A
EPS Growth	+109.71%
Outstanding Shares	1.60B

Technical Indicators

50-Day SMA	$0.63
200-Day SMA	$0.80
RSI (14)	67.58
Beta	1.05
52-Week High	$1.68
52-Week Low	$0.51

Volume Today	6.80M
Avg Daily Volume (30D)	6.36M
Relative Volume	1.07x
Volatility (10D)	73.68
Volatility (30D)	74.94
Free Float	80.15%

Analyst Consensus

BUY

Current Price $0.71

Mean Target $1.97

52W Low$0.51 52W High$1.68

Current

Target

$0.51 $1.68

Current Analyst target

+178.26% upside potential · 4 analysts

Identifiers

ExchangeHKEX

FIGIBBG00N9XPMB9

ISINKYG2588M1006

CountryChina

Sub-IndustryBiopharmaceuticals

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

REGN Regeneron Pharmaceuticals Inc -0.66% CSL.AX CSL Ltd +0.48% 207940.KS Samsung Biologics Co Ltd +1.42% UCB.BR Ucb SA -0.77% BIIB Biogen Inc +0.62%

Company Profile

CStone Pharmaceuticals is an investment holding company primarily engaged in research and development of therapies for oncology, autoimmune and inflammation, and other key disease areas. Through its subsidiaries, the Company is primarily engaged in the research and development of biopharmaceutical products, the sales of pharmaceutical products, as well as the provision of license of its intellectual property (IP) or commercialization license. The Company’s products primarily include targeted therapies, AYVAKIT (avapritinib), GAVRETO (pralsetinib) and CEJEMLY (sugemalimab). The Company is also engaged in the development and commercialization of immuno-oncology. The Company primarily conducts its businesses in the domestic market and overseas markets, such as Central and Eastern Europe and Switzerland.